Cerebral microbleeds and outcomes after reperfusion therapy in patients with acute ischemic stroke
10.3760/cma.j.issn.1673-4165.2023.12.006
- VernacularTitle:脑微出血与急性缺血性卒中患者再灌注治疗后转归
- Author:
Shuqi WEI
1
;
Weiwei ZHANG
;
Chen LI
;
Wenxuan QU
;
Feng WANG
;
Minjie LIU
Author Information
1. 荣成市人民医院神经内科，威海 264300
- Keywords:
Ischemic stroke;
Cerebral hemorrhage;
Thrombolytic therapy;
Endovascular procedures;
Thrombectomy;
Treatment outcome;
Intracranial hemorrhages
- From:
International Journal of Cerebrovascular Diseases
2023;31(12):913-917
- CountryChina
- Language:Chinese
-
Abstract:
Cerebral microbleeds (CMBs) are an imaging biomarker of cerebral small vessel disease (CSVD). Researches have shown that CMBs are a risk factor for hemorrhagic transformation and poor outcomes after reperfusion therapy in patients with acute ischemic stroke. This article reviews the relationship between CMBs and the outcomes of reperfusion therapy in patients with acute ischemic stroke.
